Sanofi, GSK launch Phase III trial for COVID-19 shot
France's Sanofi and Britain's GlaxoSmithKline launched a late-stage human trial for a recombinant COVID-19 vaccine candidate on Thursday, which they hope to get approved by the end of 2021.
The two drugmakers, reported early this month…